Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden. - Wikidata - wikimedia - TriplyDB

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

http://www.wikidata.org/entity/Q37747100

about

Effect of Hua Yu Xiao Zheng decoction on the expression levels of vascular endothelial growth factor and angiopoietin-2 in rats with endometriosis.Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.Anti-angiogenic therapies in brain metastases.

P2860

Q47128936-B984F7FD-642F-4D4A-875A-737A627C8272 Q50218607-05E9E88B-87DC-4BE4-B932-C94018777FAF Q55036256-09DFD32E-FDE4-4016-81C5-766347F27541

P2860

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

http://www.wikidata.org/entity/Q37747100

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@en

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@nl

type

label

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@en

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@nl

prefLabel

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@en

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@nl

P1433

Q37747100-6BE2B5C1-CFEE-4068-950A-FF9C05698FFA

P1476

Q37747100-B77C175D-926F-4C6A-B86D-F2901B7BE83A

P2093

Q37747100-1917DA07-F91E-498C-B9F5-0D3BEE4A4017

Q37747100-54EB2BC7-C93B-4ECA-B50A-B021E93A8662

Q37747100-722F1521-E7BA-45D0-B244-C185F642B716

Q37747100-B4C3D6F9-F64A-49B2-8480-A7E002BD833B

P2860

Q37747100-07F66F9E-213A-4460-B920-0247AA95C25D

Q37747100-119C4603-72A5-4CE8-94DD-DA33BC0DD032

Q37747100-141E0C6A-2413-4141-BCA1-24FEEEBF67F1

Q37747100-146EBF2B-EA6B-4ABC-AB1E-98E259CB3310

Q37747100-1494357B-753D-4F63-8BB4-41BC0A2D66BA

Q37747100-14C9FE5C-3A18-4B44-A553-E68DD9BF5428

Q37747100-155570A8-982A-4771-9898-860027F491FE

Q37747100-164413C9-F715-4D5D-BB2B-CDF19E91D4DA

Q37747100-1D2661C1-F4E3-42F5-AE54-83E5A5F67B60

Q37747100-1F723B46-78EF-4538-93D4-2088776AF28E

P304

Q37747100-7E83752C-EB0C-46CD-97C9-9ECA7AE42FB2

P31

Q37747100-D667A028-729B-4976-9806-2EAF2293ED5D

P356

Q37747100-27A48415-AA58-4747-A8D5-A69496963958

P478

Q37747100-75105631-AABC-4EBC-BCDF-B2B78648E600

P577

Q37747100-FDDA728F-3C94-4A52-BBFC-F4F56057B2DE

P698

Q37747100-241F14AC-841B-483B-9704-46E9794305FA

P932

Q37747100-F12886A0-650E-49A6-8CF4-3990AA75F849

P356

FPHAR.2017.00193

P1433

Frontiers in Pharmacology

P1476

Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

@en

P2093

Chris E Adkins

http://www.w3.org/2001/XMLSchema#string

Kaci A Bohn

http://www.w3.org/2001/XMLSchema#string

Mohamed I Nounou

http://www.w3.org/2001/XMLSchema#string

Paul R Lockman

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia

Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Structure and function of the blood-brain barrier

What is the evidence that tumors are angiogenesis dependent?

P304

193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00193

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28443023

http://www.w3.org/2001/XMLSchema#string

P932

5387068

http://www.w3.org/2001/XMLSchema#string